Ahmed Haider

Title: Ahmed Haider - Innovator in Radiolabeled Compounds

Introduction

Ahmed Haider is a notable inventor based in Zug, Switzerland. He has made significant contributions to the field of radiolabeled compounds, particularly in relation to cannabinoid receptor ligands. His work has implications for various applications in medical research and pharmacology.

Latest Patents

Ahmed Haider holds a patent for a compound described as a radiolabeled cannabinoid receptor 2 ligand. The patent details a compound of formula (I), where R is defined in the description and claims. This compound can be utilized as a radiolabeled ligand, showcasing its potential in scientific research.

Career Highlights

Throughout his career, Ahmed has worked with prominent organizations, including Hoffmann-La Roche Inc. and the Swiss Federal Institute of Technology Zurich (ETH Zurich). His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of radiolabeled compounds.

Collaborations

Ahmed has collaborated with esteemed colleagues such as Simon Mensah Ametamey and Juergen Fingerle. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Ahmed Haider is a distinguished inventor whose work in radiolabeled compounds has the potential to impact medical research significantly. His contributions to the field are noteworthy, and his collaborations with leading professionals further enhance the relevance of his innovations.